Literature DB >> 430433

The nature of the receptor mediating stimulant effects of histamine on rapidly adapting vagal afferents in the lungs.

S R Sampson, E H Vidruk.   

Abstract

1. The effects of histamine H1- and H2-agonists on these airway sensory receptors were also examined. 2. Neither I.V. infusion of metiamide (5 mg/kg, min for 35 min) in seven experiments, nor I.V. bolus injection of burimamide (15 mg/kg) in six other experiments, both substances being H2-antagonists, altered the response of rapidly adapting receptors to aerosols of histamine (from 0.1 or 1.0% solutions). 3. Chlorpheniramine (H1-antagonist), 2--5 mg/kg, I.V., completely abolished responses of rapidly adapting receptors to histamine in seven experiments in which metiamide had been given previously and in seven other preparations in which it had not, but had no effect on responses to prostaglandin F2 alpha. Chlorpheniramine itself caused a brief stimulation of rapidly adapting receptors. 4. The H2-agonist S-[3-(N,N-dimethylamino) propyl] isothiourea (Dimaprit), given as aerosol (1% solution for 2 min) or I.V. (2 mg/kg), was without effect on activity of four airway rapidly adapting receptors. These receptors were stimulated, however, by the H1-agonist 2,(2 pyridylethylamine) dihydrochloride (PEA), administered both as aerosol (from a 10% solution) and I.V. (0.4--2 mg/kg). These stimulant effects were abolished by chlorpheniramine. 5. The results indicate that stimulation of airway rapidly adapting receptors by histamine is mediated by histamine H1-receptors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 430433      PMCID: PMC1281509          DOI: 10.1113/jphysiol.1979.sp012673

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  11 in total

1.  Receptors in the trachea and bronchi of the cat.

Authors:  J G WIDDICOMBE
Journal:  J Physiol       Date:  1954-01       Impact factor: 5.182

2.  Stimulation of 'irritant' receptors and afferent C-fibres in the lungs by prostaglandins.

Authors:  H M Coleridge; J C Coleridge; K H Ginzel; D G Baker; R B Banzett; M A Morrison
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

3.  Histamine H1- and H2-receptors in pulmonary and systemic vasculature of the dog.

Authors:  A Tucker; E K Weir; J T Reeves; R F Grover
Journal:  Am J Physiol       Date:  1975-10

4.  Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology.

Authors:  M E Parsons; D A Owen; C R Ganellin; G J Durant
Journal:  Agents Actions       Date:  1977-03

5.  Chemical differentiation of histamine H1- and H2-receptor agonists.

Authors:  G J Durant; C R Ganellin; M E Parsons
Journal:  J Med Chem       Date:  1975-09       Impact factor: 7.446

6.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

7.  Metiamide--an orally active histamine H2-receptor antagonist.

Authors:  J W Black; W A Duncan; J C Emmett; C R Ganellin; T Hesselbo; M E Parsons; J H Wyllie
Journal:  Agents Actions       Date:  1973-10

Review 8.  Histamine (second of two parts).

Authors:  M A Beaven
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

Review 9.  Histamine (first of two parts).

Authors:  M A Beaven
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

10.  Mechanisms by which histamine stimulates rapidly adapting receptors in dog lungs.

Authors:  E H Vidruk; H L Hahn; J A Nadel; S R Sampson
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-09
View more
  2 in total

1.  Protective effect of drugs on bronchoconstriction induced by sulphur dioxide.

Authors:  W C Tan; E Cripps; N Douglas; M F Sudlow
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

2.  Histamine induced bronchoconstriction and end tidal inspiratory activity in man.

Authors:  N E Meessen; C P van der Grinten; S C Luijendijk; H T Folgering
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.